Biotechnology
The Biotechnology industry has a total of 595 stocks, with a combined market cap of $1.4 trillion and total revenue of $115.7 billion.
Market Cap
1.4T
Revenue
115.7B
Profits
-39.64B
PE Ratio
n/a
Profit Margin
-34.26%
Dividend Yield
0.04%
595 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 138.50B | 3.46% | 622,666 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 83.71B | 3.47% | 419,810 | 15.53B |
| 3 | ARGX | argenx SE | 63.98B | 2.45% | 186,177 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 62.04B | 146.82% | 143,679,324 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 45.65B | -1.39% | 596,145 | - |
| 6 | ONC | BeOne Medicines AG | 42.69B | 1.71% | 194,101 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 35.29B | 2.81% | 1,548,117 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.26B | 5.45% | 760,679 | 4.80B |
| 9 | INSM | Insmed Incorporated | 28.22B | 0.61% | 593,602 | 1.14B |
| 10 | BNTX | BioNTech SE | 28.12B | 20.70% | 6,855,360 | 3.03B |
| 11 | ROIV | Roivant Sciences Ltd. | 26.65B | -1.26% | 2,160,622 | 7.53M |
| 12 | INCY | Incyte Corporation | 25.81B | 3.12% | 529,188 | 5.82B |
| 13 | GMAB | Genmab A/S | 20.04B | 2.03% | 1,415,298 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.84B | 3.04% | 274,238 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.45B | 0.12% | 190,394 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 16.32B | 0.63% | 1,037,470 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 13.46B | 2.28% | 935,141 | 2.44B |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 13.34B | 2.90% | 834,238 | 3.41B |
| 19 | CORT | Corcept Therapeutics Incorporated | 12.94B | 1.40% | 489,518 | 830.81M |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.53B | 0.89% | 530,714 | 669.50M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.34B | 1.90% | 89,458 | 1.28B |
| 22 | HALO | Halozyme Therapeutics, Inc. | 12.18B | 2.28% | 1,370,967 | 1.66B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 11.45B | 1.35% | 182,708 | 776.57M |
| 24 | TECH | Bio-Techne Corporation | 11.29B | 0.35% | 1,378,021 | 1.22B |
| 25 | CYTK | Cytokinetics, Incorporated | 10.69B | 1.08% | 615,951 | 67.67M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 10.69B | 3.51% | 225,253 | 7.46M |
| 27 | SMMT | Summit Therapeutics Inc. | 10.42B | 1.87% | 3,201,920 | - |
| 28 | KYMR | Kymera Therapeutics, Inc. | 10.38B | 2.88% | 415,090 | 105.00M |
| 29 | ABVX | ABIVAX Société Anonyme | 10.27B | 1.30% | 466,367 | 5.67M |
| 30 | APGE | Apogee Therapeutics, Inc. | 10.16B | 0.11% | 1,000,222 | - |
| 31 | KRYS | Krystal Biotech, Inc. | 10.16B | 3.12% | 62,910 | 440.48M |
| 32 | PTGX | Protagonist Therapeutics, Inc. | 10.11B | -0.68% | 322,018 | 281.99M |
| 33 | IONS | Ionis Pharmaceuticals, Inc. | 10.07B | 1.64% | 1,326,119 | 874.09M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 9.46B | -0.53% | 472,101 | - |
| 35 | PCVX | Vaxcyte, Inc. | 9.33B | 4.83% | 659,834 | - |
| 36 | IMVT | Immunovant, Inc. | 9.22B | 0.74% | 558,798 | - |
| 37 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.99B | 0.05% | 1,233,796 | 42.16M |
| 38 | IBRX | ImmunityBio, Inc. | 8.55B | 4.53% | 8,463,873 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.99B | 0.67% | 245,938 | 239.92M |
| 40 | TGTX | TG Therapeutics, Inc. | 7.30B | 2.37% | 509,214 | 799.54M |
| 41 | ORKA | Oruka Therapeutics, Inc. | 7.15B | -4.54% | 594,455 | - |
| 42 | CGON | CG Oncology, Inc. | 7.10B | 4.99% | 452,074 | 6.23M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.79B | 3.73% | 235,454 | 618.07M |
| 44 | BLTE | Belite Bio, Inc | 6.77B | 3.47% | 78,940 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 6.67B | 0.13% | 417,069 | - |
| 46 | CAI | Caris Life Sciences, Inc. | 6.43B | 8.54% | 3,979,902 | 989.61M |
| 47 | COGT | Cogent Biosciences, Inc. | 6.42B | -1.07% | 518,476 | - |
| 48 | DNTH | Dianthus Therapeutics, Inc. | 6.33B | -1.99% | 316,468 | 1.90M |
| 49 | ERAS | Erasca, Inc. | 6.22B | -1.77% | 1,166,525 | - |
| 50 | TVTX | Travere Therapeutics, Inc. | 6.16B | 2.19% | 748,085 | 591.33M |
| 51 | PTCT | PTC Therapeutics, Inc. | 6.12B | 0.95% | 778,390 | 1.01B |
| 52 | XENE | Xenon Pharmaceuticals Inc. | 6.07B | -0.82% | 159,217 | 7.50M |
| 53 | DFTX | Definium Therapeutics, Inc. | 6.06B | -2.40% | 923,683 | - |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 5.72B | -0.15% | 120,559 | 290.54M |
| 55 | CRSP | CRISPR Therapeutics AG | 5.61B | 9.48% | 1,820,757 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.23B | 0.63% | 1,325,528 | 1.14B |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 5.03B | 4.92% | 884,296 | - |
| 58 | PBLS | Parabilis Medicines, Inc. | 4.98B | 2.41% | 285,485 | 148.00K |
| 59 | DYN | Dyne Therapeutics, Inc. | 4.91B | 1.15% | 949,317 | - |
| 60 | MANE | Veradermics, Incorporated | 4.68B | 0.71% | 317,739 | - |
| 61 | CELC | Celcuity Inc. | 4.55B | -0.26% | 266,591 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.51B | -0.10% | 946,280 | 10.35M |
| 63 | ELVN | Enliven Therapeutics, Inc. | 4.33B | -1.61% | 392,307 | - |
| 64 | LEGN | Legend Biotech Corporation | 4.33B | 2.05% | 1,514,481 | 1.27B |
| 65 | TNGX | Tango Therapeutics, Inc. | 4.25B | -0.94% | 853,786 | 53.81M |
| 66 | TLX | Telix Pharmaceuticals Limited | 4.06B | 1.51% | 58,749 | 803.79M |
| 67 | VKTX | Viking Therapeutics, Inc. | 4.05B | 4.11% | 989,935 | - |
| 68 | DNLI | Denali Therapeutics Inc. | 4.05B | 4.24% | 445,761 | 3.60M |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.91B | 3.93% | 670,402 | 117.00M |
| 70 | ABCL | AbCellera Biologics Inc. | 3.85B | 6.92% | 7,924,983 | 66.17M |
| 71 | GPCR | Structure Therapeutics Inc. | 3.82B | 0.07% | 220,540 | - |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.75B | 2.43% | 382,858 | 234.13M |
| 73 | IOVA | Iovance Biotherapeutics, Inc. | 3.55B | 11.38% | 14,663,734 | 324.97M |
| 74 | NAMS | NewAmsterdam Pharma Company N.V. | 3.38B | 3.71% | 604,672 | 7.12M |
| 75 | QURE | uniQure N.V. | 3.36B | 2.25% | 660,915 | 18.67M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.34B | 0.06% | 377,722 | 463.98M |
| 77 | CLDX | Celldex Therapeutics, Inc. | 3.30B | 0.50% | 644,352 | 158.00K |
| 78 | IMNM | Immunome, Inc. | 3.28B | 4.83% | 1,306,162 | 4.02M |
| 79 | MBX | MBX Biosciences, Inc. | 3.23B | 0.96% | 252,284 | - |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 3.17B | 1.65% | 295,287 | 606.33M |
| 81 | ALMS | Alumis Inc. | 3.15B | -2.21% | 372,755 | 7.40M |
| 82 | IRON | Disc Medicine, Inc. | 3.07B | -0.14% | 150,901 | - |
| 83 | ZLAB | Zai Lab Limited | 2.98B | 3.91% | 964,334 | 449.61M |
| 84 | NRIX | Nurix Therapeutics, Inc. | 2.92B | 4.34% | 977,237 | 36.77M |
| 85 | BEAM | Beam Therapeutics Inc. | 2.81B | 5.98% | 1,903,498 | 156.04M |
| 86 | SLS | SELLAS Life Sciences Group, Inc. | 2.78B | 5.27% | 6,139,401 | - |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.78B | 2.51% | 1,003,750 | 71.13M |
| 88 | ATAI | AtaiBeckley Inc. | 2.72B | 0.55% | 5,061,246 | 4.47M |
| 89 | TRVI | Trevi Therapeutics, Inc. | 2.65B | -1.33% | 450,239 | - |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.59B | 3.53% | 754,116 | 717.00M |
| 91 | NKTR | Nektar Therapeutics | 2.57B | 2.40% | 208,513 | 54.59M |
| 92 | NUVB | Nuvation Bio Inc. | 2.57B | 5.17% | 7,811,302 | 169.90M |
| 93 | PHVS | Pharvaris N.V. | 2.54B | 0.08% | 453,584 | - |
| 94 | OCUL | Ocular Therapeutix, Inc. | 2.51B | 4.00% | 1,571,602 | 52.06M |
| 95 | PGEN | Precigen, Inc. | 2.51B | 3.70% | 4,311,688 | 85.72M |
| 96 | KOD | Kodiak Sciences Inc. | 2.49B | -2.44% | 189,266 | - |
| 97 | URGN | UroGen Pharma Ltd. | 2.46B | 2.90% | 1,594,588 | 188.73M |
| 98 | COAG | Hemab Therapeutics Holdings, Inc. | 2.39B | -2.23% | 136,986 | - |
| 99 | MLYS | Mineralys Therapeutics, Inc. | 2.38B | 1.05% | 481,421 | - |
| 100 | RAPP | Rapport Therapeutics, Inc. | 2.36B | 0.24% | 93,539 | 20.00M |
| 101 | KLRA | Kailera Therapeutics, Inc. | 2.34B | 1.15% | 699,385 | - |
| 102 | VERA | Vera Therapeutics, Inc. | 2.31B | -0.81% | 697,350 | - |
| 103 | HRMY | Harmony Biosciences Holdings, Inc. | 2.28B | 1.03% | 264,991 | 959.90M |
| 104 | VCEL | Vericel Corporation | 2.27B | 0.25% | 299,332 | 306.30M |
| 105 | ADMA | ADMA Biologics, Inc. | 2.25B | 5.24% | 1,221,115 | 512.28M |
| 106 | GENB | Generate Biomedicines, Inc. | 2.19B | 6.34% | 803,012 | 26.48M |
| 107 | MESO | Mesoblast Limited | 2.19B | 1.62% | 59,630 | 65.38M |
| 108 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | 4.38% | 862,457 | 311.51M |
| 109 | STOK | Stoke Therapeutics, Inc. | 2.12B | 2.33% | 753,072 | 27.59M |
| 110 | PVLA | Palvella Therapeutics, Inc. | 2.12B | -2.21% | 60,309 | - |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 2.12B | 3.08% | 369,878 | 98.34M |
| 112 | BHVN | Biohaven Ltd. | 2.11B | 3.02% | 820,052 | - |
| 113 | NBTX | Nanobiotix S.A. | 2.07B | 8.54% | 92,429 | 38.27M |
| 114 | TSHA | Taysha Gene Therapies, Inc. | 2.07B | 2.50% | 795,487 | 5.49M |
| 115 | ZBIO | Zenas BioPharma, Inc. | 2.06B | -0.91% | 1,320,946 | 1.00M |
| 116 | KARD | Kardigan, Inc. | 2.06B | 5.21% | 125,022 | - |
| 117 | GHRS | GH Research PLC | 2.06B | 0.72% | 227,710 | - |
| 118 | SEPN | Septerna, Inc. | 2.05B | 0.48% | 132,580 | 98.88M |
| 119 | SRPT | Sarepta Therapeutics, Inc. | 2.04B | 7.10% | 2,772,562 | 1.97B |
| 120 | XNCR | Xencor, Inc. | 2.00B | 5.63% | 1,395,109 | 104.97M |
| 121 | DMRA | Damora Therapeutics, Inc. | 1.96B | -0.11% | 185,446 | - |
| 122 | ZYME | Zymeworks Inc. | 1.96B | 5.87% | 337,755 | 37.13M |
| 123 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.08% | 6,291,901 | - |
| 124 | IMCR | Immunocore Holdings plc | 1.89B | 1.97% | 443,849 | 430.78M |
| 125 | SNDX | Syndax Pharmaceuticals, Inc. | 1.84B | 3.54% | 366,885 | 252.25M |
| 126 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.83B | 23.00% | 9,235,640 | 208.78M |
| 127 | RXRX | Recursion Pharmaceuticals, Inc. | 1.83B | 10.36% | 18,954,026 | 54.86M |
| 128 | BRVE | Braveheart Bio, Inc. | 1.82B | 6.13% | 242,131 | - |
| 129 | LKFT | Lakefront Biotherapeutics NV | 1.81B | 5.18% | 196,389 | 1.13B |
| 130 | NTLA | Intellia Therapeutics, Inc. | 1.79B | 10.17% | 2,727,246 | 59.51M |
| 131 | ANAB | AnaptysBio, Inc. | 1.74B | -0.63% | 104,389 | 232.39M |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.73B | 4.98% | 256,010 | - |
| 133 | AVLN | Avalyn Pharma Inc. | 1.72B | -0.01% | 55,311 | - |
| 134 | FTRE | Fortrea Holdings Inc. | 1.71B | 2.44% | 358,442 | 2.68B |
| 135 | ABSI | Absci Corporation | 1.70B | 11.75% | 2,748,964 | 1.56M |
| 136 | TRAX | First Tracks Biotherapeutics, Inc. | 1.64B | 4.52% | 365,400 | - |
| 137 | AAPG | Ascentage Pharma Group International | 1.63B | 0.06% | 1,628 | 82.08M |
| 138 | VIR | Vir Biotechnology, Inc. | 1.63B | 1.48% | 962,364 | 303.23M |
| 139 | MAZE | Maze Therapeutics, Inc. | 1.63B | 0.58% | 164,007 | 20.00M |
| 140 | TYRA | Tyra Biosciences, Inc. | 1.57B | 1.31% | 109,966 | - |
| 141 | LBRX | LB Pharmaceuticals Inc | 1.57B | -0.39% | 63,927 | - |
| 142 | INVA | Innoviva, Inc. | 1.56B | 1.55% | 223,418 | 440.00M |
| 143 | SLBT | SL Science Holding Limited | 1.52B | -2.17% | 14,626 | 3.27M |
| 144 | ORIC | ORIC Pharmaceuticals, Inc. | 1.49B | 3.30% | 683,191 | - |
| 145 | AVBP | ArriVent BioPharma, Inc. | 1.46B | -1.13% | 225,374 | - |
| 146 | INBX | Inhibrx Biosciences, Inc. | 1.45B | 4.21% | 177,245 | 1.30M |
| 147 | NVAX | Novavax, Inc. | 1.44B | 9.96% | 7,670,341 | 413.80M |
| 148 | JBIO | Jade Biosciences, Inc. | 1.43B | -4.33% | 381,438 | - |
| 149 | MLTX | MoonLake Immunotherapeutics | 1.42B | 2.33% | 801,516 | - |
| 150 | VOR | Vor Biopharma Inc. | 1.42B | 3.09% | 517,905 | - |
| 151 | REPL | Replimune Group, Inc. | 1.41B | -3.92% | 2,370,471 | - |
| 152 | CGEM | Cullinan Therapeutics, Inc. | 1.41B | 4.89% | 249,961 | - |
| 153 | SVRA | Savara Inc. | 1.41B | 3.07% | 561,474 | - |
| 154 | MGTX | MeiraGTx Holdings plc | 1.40B | 4.90% | 535,079 | 397.50M |
| 155 | MNKD | MannKind Corporation | 1.40B | 6.76% | 2,883,401 | 393.63M |
| 156 | AKTS | Aktis Oncology, Inc. | 1.37B | -1.20% | 109,082 | 10.06M |
| 157 | ANRO | Alto Neuroscience, Inc. | 1.34B | 0.38% | 166,516 | - |
| 158 | GLUE | Monte Rosa Therapeutics, Inc. | 1.34B | 4.62% | 498,716 | 28.73M |
| 159 | OMER | Omeros Corporation | 1.33B | 7.27% | 2,130,829 | 38.42M |
| 160 | DRTS | Alpha Tau Medical Ltd. | 1.33B | 1.05% | 470,790 | - |
| 161 | SPTX | Seaport Therapeutics, Inc. | 1.31B | 2.09% | 157,120 | - |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 1.28B | 2.83% | 316,556 | - |
| 163 | APMD | Apnimed, Inc. | 1.28B | 1.19% | 71,564 | 120.15M |
| 164 | LTGO | Latigo Biotherapeutics, Inc. | 1.28B | 1.05% | 91,722 | - |
| 165 | IMTX | Immatics N.V. | 1.24B | -0.11% | 378,231 | 47.65M |
| 166 | SANA | Sana Biotechnology, Inc. | 1.19B | 9.09% | 4,381,583 | - |
| 167 | ODTX | Odyssey Therapeutics, Inc. | 1.15B | 9.50% | 82,496 | 99.00K |
| 168 | KURA | Kura Oncology, Inc. | 1.12B | 2.19% | 2,067,203 | 77.23M |
| 169 | AVTX | Avalo Therapeutics, Inc. | 1.11B | 5.02% | 556,727 | 59.00K |
| 170 | JANX | Janux Therapeutics, Inc. | 1.08B | 4.42% | 517,356 | 24.00M |
| 171 | WVE | Wave Life Sciences, Inc. | 1.08B | 3.59% | 1,433,888 | 65.37M |
| 172 | IVA | Inventiva S.A. | 1.07B | 2.16% | 336,740 | 7.94M |
| 173 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.07B | -0.62% | 1,060,033 | 41.47M |
| 174 | CADL | Candel Therapeutics, Inc. | 1.03B | 11.62% | 1,376,260 | - |
| 175 | SLDB | Solid Biosciences Inc. | 1.03B | 5.40% | 559,834 | - |
| 176 | ANNX | Annexon, Inc. | 1.02B | 2.18% | 1,589,695 | - |
| 177 | ARDX | Ardelyx, Inc. | 1.01B | 3.06% | 1,274,361 | 450.89M |
| 178 | GERN | Geron Corporation | 992.62M | 0.98% | 3,742,454 | 204.56M |
| 179 | ABUS | Arbutus Biopharma Corporation | 983.30M | 2.69% | 2,176,865 | 181.72M |
| 180 | DSGN | Design Therapeutics, Inc. | 972.52M | 1.77% | 318,367 | - |
| 181 | ATTO | Attovia Therapeutics, Inc. | 962.13M | -3.79% | 220,144 | 1.35M |
| 182 | CLYM | Climb Bio, Inc. | 956.89M | -4.20% | 703,719 | - |
| 183 | OLMA | Olema Pharmaceuticals, Inc. | 945.85M | 1.50% | 948,316 | - |
| 184 | ACRS | Aclaris Therapeutics, Inc. | 926.62M | -0.16% | 911,743 | 8.22M |
| 185 | IMMX | Immix Biopharma, Inc. | 914.27M | 8.21% | 1,091,557 | - |
| 186 | SGP | SpyGlass Pharma, Inc. | 911.46M | 5.46% | 77,306 | - |
| 187 | ANL | Adlai Nortye Ltd. | 908.98M | -0.32% | 96,034 | 18.06M |
| 188 | FDMT | 4D Molecular Therapeutics, Inc. | 896.61M | 10.26% | 1,080,367 | 92.01M |
| 189 | TBPH | Theravance Biopharma, Inc. | 882.36M | 0.27% | 73,265 | 104.31M |
| 190 | FTH | Faeth Therapeutics, Inc. | 878.06M | 2.97% | 130,742 | - |
| 191 | DBVT | DBV Technologies S.A. | 877.60M | 1.94% | 114,935 | 5.04M |
| 192 | ACHV | Achieve Life Sciences, Inc. | 876.73M | 13.30% | 2,024,419 | - |
| 193 | RIGL | Rigel Pharmaceuticals, Inc. | 862.08M | 5.80% | 191,789 | 276.79M |
| 194 | OBX | Obsidian Therapeutics, Inc. | 840.53M | -2.76% | 18,780 | - |
| 195 | SLN | Silence Therapeutics plc | 824.87M | -2.84% | 524,787 | 615.00K |
| 196 | OCS | Oculis Holding AG | 822.89M | 1.06% | 158,129 | 1.45M |
| 197 | DRUG | Bright Minds Biosciences Inc. | 814.40M | 0.36% | 84,219 | - |
| 198 | PHAR | Pharming Group N.V. | 813.90M | -0.46% | 12,155 | 366.48M |
| 199 | AURA | Aura Biosciences, Inc. | 813.05M | -3.92% | 487,051 | - |
| 200 | MNPR | Monopar Therapeutics Inc. | 805.06M | 0.75% | 188,821 | - |
| 201 | CTMX | CytomX Therapeutics, Inc. | 776.81M | 5.16% | 2,316,074 | 18.30M |
| 202 | RGNX | REGENXBIO Inc. | 774.33M | 5.96% | 424,223 | 174.48M |
| 203 | NGNE | Neurogene Inc. | 772.44M | 8.21% | 92,745 | 925.00K |
| 204 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 770.47M | 7.37% | 186,817 | - |
| 205 | NVCT | Nuvectis Pharma, Inc. | 761.76M | 11.81% | 172,300 | - |
| 206 | GYRE | Gyre Therapeutics, Inc. | 759.73M | 2.65% | 53,800 | 109.82M |
| 207 | STTK | Shattuck Labs, Inc. | 753.23M | 0.74% | 307,052 | 1.00M |
| 208 | PHAT | Phathom Pharmaceuticals, Inc. | 751.81M | 2.32% | 369,856 | 239.66M |
| 209 | ALLO | Allogene Therapeutics, Inc. | 737.62M | 5.17% | 4,112,898 | 4.64M |
| 210 | HELP | Cybin Inc. | 733.27M | 1.37% | 407,305 | - |
| 211 | CBIO | Crescent Biopharma, Inc. | 728.90M | 2.04% | 64,624 | 11.88M |
| 212 | TECX | Tectonic Therapeutic, Inc. | 720.20M | 0.63% | 108,636 | - |
| 213 | ZVRA | Zevra Therapeutics, Inc. | 709.64M | 3.28% | 432,789 | 136.07M |
| 214 | AGMB | AgomAb Therapeutics NV | 677.16M | 0.15% | 81,422 | - |
| 215 | ASMB | Assembly Biosciences, Inc. | 676.99M | 3.49% | 150,210 | 74.85M |
| 216 | SGMT | Sagimet Biosciences Inc. | 665.72M | 1.23% | 900,528 | - |
| 217 | VSTM | Verastem, Inc. | 664.74M | -1.21% | 1,211,482 | 87.53M |
| 218 | EIKN | Eikon Therapeutics, Inc. | 657.29M | 4.16% | 827,768 | - |
| 219 | AUTL | Autolus Therapeutics plc | 652.10M | 6.99% | 4,321,162 | 117.39M |
| 220 | MDXG | MiMedx Group, Inc. | 651.55M | 3.00% | 443,661 | 355.17M |
| 221 | VALN | Valneva SE | 647.09M | -0.58% | 43,440 | 163.30M |
| 222 | CRMD | CorMedix Inc. | 637.58M | 0.12% | 630,011 | 462.25M |
| 223 | SPRY | ARS Pharmaceuticals, Inc. | 635.47M | 1.43% | 625,214 | 116.93M |
| 224 | ARVN | Arvinas, Inc. | 627.05M | 3.56% | 287,682 | 316.70M |
| 225 | PRME | Prime Medicine, Inc. | 620.89M | 14.43% | 3,860,206 | 4.07M |
| 226 | ALT | Altimmune, Inc. | 616.62M | 6.73% | 6,153,883 | 31.00K |
| 227 | SCTX | Scribe Therapeutics Inc. | 612.53M | 19.77% | 290,811 | 36.28M |
| 228 | PRLD | Prelude Therapeutics Incorporated | 598.40M | 1.04% | 205,551 | 22.42M |
| 229 | OABI | OmniAb, Inc. | 580.11M | 1.79% | 1,899,459 | 38.46M |
| 230 | CTNM | Contineum Therapeutics, Inc. | 571.46M | 4.76% | 259,470 | - |
| 231 | ARTV | Artiva Biotherapeutics, Inc. | 569.08M | -0.34% | 224,478 | 251.00K |
| 232 | OVID | Ovid Therapeutics Inc. | 567.34M | 2.29% | 1,100,370 | 1.58M |
| 233 | ZURA | Zura Bio Limited | 554.85M | 0.35% | 582,530 | - |
| 234 | MPLT | MapLight Therapeutics, Inc. | 551.43M | 0.59% | 323,588 | - |
| 235 | KYTX | Kyverna Therapeutics, Inc. | 542.99M | 3.29% | 496,036 | - |
| 236 | EVMN | Evommune, Inc. | 537.49M | 4.15% | 160,375 | 10.00M |
| 237 | CCCC | C4 Therapeutics, Inc. | 530.85M | 3.23% | 1,575,064 | 35.04M |
| 238 | CABA | Cabaletta Bio, Inc. | 527.29M | 6.87% | 7,523,738 | - |
| 239 | ENTX | Entera Bio Ltd. | 522.89M | 4.50% | 430,292 | 42.00K |
| 240 | RLMD | Relmada Therapeutics, Inc. | 514.15M | -0.62% | 308,360 | - |
| 241 | EYPT | EyePoint, Inc. | 512.96M | 8.78% | 5,465,859 | 2.79M |
| 242 | DNA | Ginkgo Bioworks Holdings, Inc. | 506.40M | 15.16% | 1,436,007 | 132.42M |
| 243 | BLSM | BlossomHill Therapeutics, Inc. | 493.36M | - | 135,254 | - |
| 244 | RZLT | Rezolute, Inc. | 488.90M | 0.43% | 524,279 | - |
| 245 | OCGN | Ocugen, Inc. | 483.23M | 6.34% | 3,938,994 | 4.58M |
| 246 | EDIT | Editas Medicine, Inc. | 482.24M | 9.03% | 4,999,269 | 47.01M |
| 247 | PBYI | Puma Biotechnology, Inc. | 478.00M | 0.22% | 100,274 | 231.24M |
| 248 | PRTA | Prothena Corporation plc | 467.26M | 4.50% | 140,182 | 54.53M |
| 249 | QTTB | Q32 Bio Inc. | 462.32M | 1.57% | 104,783 | 53.74M |
| 250 | EPRX | Eupraxia Pharmaceuticals Inc. | 450.72M | 1.53% | 301,299 | - |
| 251 | CMPX | Compass Therapeutics, Inc. | 448.42M | 4.18% | 1,772,467 | 850.00K |
| 252 | BNTC | Benitec Biopharma Inc. | 446.61M | 0.93% | 43,979 | - |
| 253 | IKT | Inhibikase Therapeutics, Inc. | 445.17M | 1.87% | 340,353 | 1.00 |
| 254 | PROK | ProKidney Corp. | 441.39M | 5.80% | 747,363 | 818.00K |
| 255 | LRMR | Larimar Therapeutics, Inc. | 437.36M | 3.20% | 641,678 | - |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 437.12M | 3.22% | 174,617 | - |
| 257 | LXEO | Lexeo Therapeutics, Inc. | 429.90M | 6.29% | 450,634 | - |
| 258 | CAPR | Capricor Therapeutics, Inc. | 428.48M | 4.10% | 5,485,822 | 11.13M |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 414.93M | -0.59% | 200,574 | 15.85M |
| 260 | FENC | Fennec Pharmaceuticals Inc. | 413.79M | -0.59% | 71,708 | 59.22M |
| 261 | FHTX | Foghorn Therapeutics Inc. | 407.09M | 1.56% | 158,065 | 36.74M |
| 262 | VTVT | vTv Therapeutics Inc. | 404.80M | 3.49% | 16,695 | 36.84M |
| 263 | LYEL | Lyell Immunopharma, Inc. | 397.35M | 2.69% | 66,782 | 27.00K |
| 264 | ENTA | Enanta Pharmaceuticals, Inc. | 391.30M | 1.02% | 47,363 | 65.26M |
| 265 | RCKT | Rocket Pharmaceuticals, Inc. | 389.70M | 6.29% | 800,010 | - |
| 266 | UPB | Upstream Bio, Inc. | 388.33M | 3.50% | 288,964 | 3.16M |
| 267 | AGEN | Agenus Inc. | 383.57M | 13.15% | 1,703,609 | 132.69M |
| 268 | IPSC | Century Therapeutics, Inc. | 376.64M | 6.12% | 256,328 | 109.16M |
| 269 | PALI | Palisade Bio, Inc. | 372.94M | 4.90% | 1,387,658 | 500.00K |
| 270 | CUVL | Clinuvel Pharmaceuticals Limited | 372.08M | 2.20% | 4,012 | 64.24M |
| 271 | GALT | Galectin Therapeutics Inc. | 371.13M | 4.55% | 214,652 | - |
| 272 | STRO | Sutro Biopharma, Inc. | 367.77M | 0.64% | 45,870 | 45.70M |
| 273 | DMAC | DiaMedica Therapeutics Inc. | 361.30M | 1.36% | 69,838 | - |
| 274 | ABEO | Abeona Therapeutics Inc. | 355.97M | 1.06% | 540,528 | 25.52M |
| 275 | ZNTL | Zentalis Pharmaceuticals, Inc. | 355.49M | 2.04% | 962,750 | 26.87M |
| 276 | SABS | SAB Biotherapeutics, Inc. | 345.75M | 0.26% | 549,473 | 114.70K |
| 277 | IMRX | Immuneering Corporation | 342.25M | 5.17% | 447,932 | - |
| 278 | OBIO | Orchestra BioMed Holdings, Inc. | 340.80M | 0.18% | 289,657 | 31.98M |
| 279 | VNDA | Vanda Pharmaceuticals Inc. | 330.73M | 0.55% | 404,319 | 215.72M |
| 280 | VCRE | Vicore Pharma Holding AB (publ) | 327.24M | -3.11% | 4,407 | 370.61K |
| 281 | FATE | Fate Therapeutics, Inc. | 321.12M | 4.69% | 604,083 | 6.49M |
| 282 | IRD | Opus Genetics, Inc. | 319.89M | 4.20% | 275,305 | 9.86M |
| 283 | VOGX | Vogenx, Inc. | 317.11M | 15.37% | 352,291 | - |
| 284 | PRQR | ProQR Therapeutics N.V. | 316.11M | 4.19% | 642,992 | 21.05M |
| 285 | IFRX | InflaRx N.V. | 315.37M | -1.83% | 278,119 | -11.54K |
| 286 | RNAC | Cartesian Therapeutics, Inc. | 311.21M | 11.80% | 210,150 | 1.48M |
| 287 | NMRA | Neumora Therapeutics, Inc. | 309.09M | 0.30% | 448,813 | - |
| 288 | AVXL | Anavex Life Sciences Corp. | 307.21M | 3.59% | 368,644 | - |
| 289 | FULC | Fulcrum Therapeutics, Inc. | 295.65M | 0.13% | 1,141,392 | 80.00M |
| 290 | CAMP | Camp4 Therapeutics Corporation | 295.57M | -3.88% | 152,451 | 4.22M |
| 291 | TTRX | Turn Therapeutics Inc. | 293.71M | -1.30% | 13,531 | - |
| 292 | YDES | YD Bio Limited | 292.93M | 4.67% | 63,546 | 510.36K |
| 293 | ELDN | Eledon Pharmaceuticals, Inc. | 288.76M | -1.93% | 470,436 | - |
| 294 | BCYC | Bicycle Therapeutics plc | 288.37M | 3.26% | 115,739 | 61.21M |
| 295 | ALXO | ALX Oncology Holdings Inc. | 285.54M | -0.72% | 806,598 | - |
| 296 | WHWK | Whitehawk Therapeutics, Inc. | 283.33M | 4.41% | 179,540 | 7.15M |
| 297 | SRZN | Surrozen, Inc. | 281.97M | -0.04% | 77,087 | 11.51M |
| 298 | LCTX | Lineage Cell Therapeutics, Inc. | 279.46M | 4.25% | 555,992 | 13.08M |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 279.11M | 19.61% | 4,695,932 | 29.37M |
| 300 | PYXS | Pyxis Oncology, Inc. | 275.25M | 10.37% | 744,855 | 11.04M |
| 301 | TRDA | Entrada Therapeutics, Inc. | 275.11M | 4.95% | 110,922 | 4.69M |
| 302 | SION | Sionna Therapeutics, Inc. | 274.89M | 2.36% | 894,776 | - |
| 303 | ALEC | Alector, Inc. | 274.68M | 11.31% | 2,590,071 | 13.86M |
| 304 | ADAG | Adagene Inc. | 273.94M | 0.74% | 206,711 | 9.29M |
| 305 | IVVD | Invivyd, Inc. | 273.18M | 6.76% | 3,522,338 | 58.37M |
| 306 | MGNX | MacroGenics, Inc. | 266.27M | 2.20% | 222,836 | 175.14M |
| 307 | SLGL | Sol-Gel Technologies Ltd. | 262.09M | 1.07% | 22,755 | 18.47M |
| 308 | GLSI | Greenwich LifeSciences, Inc. | 257.46M | 1.62% | 84,325 | - |
| 309 | ACIU | AC Immune SA | 256.52M | 0.39% | 182,581 | 21.67M |
| 310 | NAGE | Niagen Bioscience, Inc. | 255.72M | 5.39% | 543,689 | 129.08M |
| 311 | DTIL | Precision BioSciences, Inc. | 237.93M | 4.74% | 303,434 | 45.06M |
| 312 | TARA | Protara Therapeutics, Inc. | 235.79M | 0.25% | 173,753 | - |
| 313 | CLLS | Cellectis S.A. | 232.55M | 3.62% | 2,818 | 63.82M |
| 314 | CNXU | Conexeu Sciences Inc. | 230.66M | -13.71% | 297,729 | - |
| 315 | NERV | Minerva Neurosciences, Inc. | 228.71M | 5.51% | 125,865 | - |
| 316 | RNA | Atrium Therapeutics, Inc. | 228.36M | 3.97% | 177,424 | 35.84M |
| 317 | CGEN | Compugen Ltd. | 227.34M | 0.84% | 112,297 | 74.00M |
| 318 | NBP | NovaBridge Biosciences | 227.25M | 3.97% | 199,092 | - |
| 319 | IMUX | Immunic, Inc. | 225.27M | -2.31% | 89,837 | - |
| 320 | ANTX | AN2 Therapeutics, Inc. | 224.53M | -0.34% | 137,017 | - |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 218.25M | 0.51% | 427,537 | 29.10M |
| 322 | ABOS | Acumen Pharmaceuticals, Inc. | 218.04M | 10.04% | 373,139 | - |
| 323 | KROS | Keros Therapeutics, Inc. | 213.64M | 1.56% | 59,685 | 15.01M |
| 324 | VYGR | Voyager Therapeutics, Inc. | 210.73M | 3.64% | 447,874 | 34.46M |
| 325 | KRRO | Korro Bio, Inc. | 207.63M | 6.66% | 72,383 | 2.38M |
| 326 | PEPG | PepGen Inc. | 207.09M | 2.75% | 446,239 | - |
| 327 | CHRS | Coherus Oncology, Inc. | 204.71M | -1.12% | 2,259,871 | 50.94M |
| 328 | MSLE | Satellos Bioscience Inc. | 202.29M | 4.38% | 25,685 | - |
| 329 | ORMP | Oramed Pharmaceuticals Inc. | 199.67M | 0.42% | 274,490 | 2.00M |
| 330 | HUMA | Humacyte, Inc. | 196.82M | 21.80% | 12,829,112 | 2.12M |
| 331 | ACOG | Alpha Cognition Inc. | 195.97M | 4.96% | 68,883 | 15.26M |
| 332 | IPHA | Innate Pharma S.A. | 195.33M | 1.93% | 19,215 | 10.57M |
| 333 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 192.45M | -1.29% | 202,450 | - |
| 334 | PLX | Protalix BioTherapeutics, Inc. | 189.34M | 0.43% | 294,448 | 80.62M |
| 335 | NGEN | NervGen Pharma Corp. | 183.03M | 0.58% | 301,599 | - |
| 336 | ARMP | Armata Pharmaceuticals, Inc. | 181.45M | 7.02% | 75,453 | 5.54M |
| 337 | NKTX | Nkarta, Inc. | 179.78M | 4.15% | 372,243 | - |
| 338 | MDWD | MediWound Ltd. | 177.06M | 0.55% | 34,405 | 11.86M |
| 339 | CRBU | Caribou Biosciences, Inc. | 174.21M | 4.17% | 580,645 | 10.04M |
| 340 | CDXS | Codexis, Inc. | 173.02M | 5.33% | 1,071,626 | 77.68M |
| 341 | OKUR | OnKure Therapeutics, Inc. | 170.08M | -0.24% | 92,580 | - |
| 342 | CNTN | Canton Strategic Holdings, Inc. | 165.74M | 3.48% | 546,508 | 1.50M |
| 343 | KZIA | Kazia Therapeutics Limited | 163.75M | -0.35% | 96,156 | 1.27M |
| 344 | MOLN | Molecular Partners AG | 162.97M | 3.61% | 433 | 856.30K |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 159.54M | 1.86% | 1,291,013 | 1.34M |
| 346 | UNCY | Unicycive Therapeutics, Inc. | 156.55M | -0.18% | 506,139 | - |
| 347 | CNTB | Connect Biopharma Holdings Limited | 155.23M | 1.44% | 281,404 | 2.95M |
| 348 | MIST | Milestone Pharmaceuticals Inc. | 155.00M | 2.80% | 1,692,960 | 2.34M |
| 349 | LENZ | LENZ Therapeutics, Inc. | 153.02M | 2.10% | 260,956 | 21.48M |
| 350 | SPRB | Spruce Biosciences, Inc. | 150.97M | -0.60% | 71,753 | 697.00K |
| 351 | MENS | Jyong Biotech Ltd. | 150.32M | 0.25% | 32,559 | - |
| 352 | EQ | Equillium, Inc. | 147.95M | -0.43% | 147,596 | 4.39M |
| 353 | AARD | Aardvark Therapeutics, Inc. | 145.75M | 8.38% | 84,765 | - |
| 354 | HURA | TuHURA Biosciences, Inc. | 142.97M | 3.94% | 97,189 | - |
| 355 | NRXP | NRx Pharmaceuticals, Inc. | 142.08M | -1.45% | 485,402 | 3.39M |
| 356 | TLSA | Tiziana Life Sciences Ltd | 139.01M | -4.02% | 959,670 | - |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 132.35M | 6.67% | 5,006,789 | 65.34K |
| 358 | OTLK | Outlook Therapeutics, Inc. | 130.92M | 0.01% | 11,932,395 | -1.16M |
| 359 | PMN | ProMIS Neurosciences, Inc. | 130.03M | -3.20% | 16,177 | - |
| 360 | ANIX | Anixa Biosciences, Inc. | 128.95M | 10.50% | 419,214 | - |
| 361 | CBUS | Cibus, Inc. | 128.61M | 3.23% | 56,159 | 4.35M |
| 362 | RANI | Rani Therapeutics Holdings, Inc. | 126.57M | 10.01% | 912,679 | 4.88M |
| 363 | BDTX | Black Diamond Therapeutics, Inc. | 125.25M | 5.83% | 614,089 | 70.00M |
| 364 | VANI | Vivani Medical, Inc. | 123.32M | -1.38% | 524,610 | - |
| 365 | ENGN | enGene Therapeutics Inc. | 121.25M | 5.23% | 574,309 | - |
| 366 | NTHI | NeOnc Technologies Holdings, Inc. | 120.80M | -12.12% | 257,001 | 39.99K |
| 367 | GNLX | Genelux Corporation | 117.68M | 1.92% | 114,577 | 8.00K |
| 368 | COYA | Coya Therapeutics, Inc. | 116.35M | 0.81% | 53,027 | 8.02M |
| 369 | GUTS | Fractyl Health, Inc. | 115.58M | 1.26% | 469,205 | 3.00K |
| 370 | NAUT | Nautilus Biotechnology, Inc. | 114.98M | 6.07% | 342,599 | 190.00K |
| 371 | SEER | Seer, Inc. | 114.34M | 2.23% | 133,823 | 14.22M |
| 372 | YARW | Yarrow Bioscience, Inc. | 113.12M | -2.70% | 23,521 | - |
| 373 | CUE | Cue Biopharma, Inc. | 110.68M | 2.53% | 93,799 | 37.66M |
| 374 | INDP | Indaptus Therapeutics, Inc. | 107.58M | 1.48% | 663,550 | - |
| 375 | ONCY | Oncolytics Biotech Inc. | 106.24M | -1.38% | 379,750 | - |
| 376 | TENX | Tenax Therapeutics, Inc. | 104.25M | 7.06% | 3,774,462 | - |
| 377 | PLYX | Polaryx Therapeutics, Inc. | 102.68M | -1.44% | 97,509 | - |
| 378 | KLRS | Kalaris Therapeutics, Inc. | 101.89M | 6.20% | 53,913 | - |
| 379 | ACET | Adicet Bio, Inc. | 100.00M | 1.98% | 28,631 | - |
| 380 | PYPD | PolyPid Ltd. | 98.51M | 2.54% | 47,983 | - |
| 381 | BMEA | Biomea Fusion, Inc. | 97.13M | -0.74% | 810,713 | - |
| 382 | FBIO | Fortress Biotech, Inc. | 94.22M | -2.92% | 299,789 | 68.47M |
| 383 | ALDX | Aldeyra Therapeutics, Inc. | 93.81M | 0.32% | 551,375 | - |
| 384 | ATRA | Atara Biotherapeutics, Inc. | 93.25M | 6.54% | 21,190 | 6.19M |
| 385 | CGTX | Cognition Therapeutics, Inc. | 93.07M | -0.33% | 687,966 | - |
| 386 | ACRV | Acrivon Therapeutics, Inc. | 91.71M | 4.39% | 290,573 | - |
| 387 | PTHS | Pelthos Therapeutics Inc. | 91.37M | 0.69% | 10,247 | 43.30M |
| 388 | ICCC | ImmuCell Corporation | 90.00M | 1.54% | 8,572 | 30.68M |
| 389 | RLYB | Rallybio Corporation | 89.80M | 0.83% | 12,373 | 646.00K |
| 390 | GANX | Gain Therapeutics, Inc. | 89.17M | 0.65% | 145,098 | - |
| 391 | MAIA | MAIA Biotechnology, Inc. | 85.16M | 2.19% | 205,994 | - |
| 392 | VRCA | Verrica Pharmaceuticals Inc. | 85.03M | 5.77% | 118,451 | 30.32M |
| 393 | ELTX | Elicio Therapeutics, Inc. | 81.08M | -0.80% | 379,448 | - |
| 394 | TELO | Telomir Pharmaceuticals, Inc. | 80.47M | 8.33% | 79,733 | - |
| 395 | DWTX | Dogwood Therapeutics, Inc. | 79.88M | 9.81% | 70,262 | - |
| 396 | NRXS | NeurAxis, Inc. | 78.90M | 0.37% | 32,234 | 5.32M |
| 397 | ANVS | Annovis Bio, Inc. | 78.28M | 2.22% | 508,831 | - |
| 398 | ATHE | Alterity Therapeutics Limited | 78.20M | 1.75% | 27,530 | 4.43M |
| 399 | OKYO | OKYO Pharma Limited | 78.19M | -1.32% | 125,835 | - |
| 400 | LONA | LeonaBio, Inc. | 77.03M | 0.37% | 9,066 | - |
| 401 | CING | Cingulate Inc. | 75.04M | -0.77% | 97,463 | - |
| 402 | GOSS | Gossamer Bio, Inc. | 74.50M | 6.50% | 3,849,175 | 53.29M |
| 403 | PLRX | Pliant Therapeutics, Inc. | 72.45M | 1.74% | 582,845 | - |
| 404 | SPRO | Spero Therapeutics, Inc. | 71.34M | 2.08% | 323,094 | 47.00M |
| 405 | ELOX | Eloxx Pharmaceuticals, Inc. | 71.04M | -3.56% | 50,269 | - |
| 406 | IBIO | iBio, Inc. | 71.04M | -1.38% | 548,834 | 300.00K |
| 407 | SER | Serina Therapeutics, Inc. | 70.61M | 6.11% | 87,784 | 130.00K |
| 408 | XBIT | XBiotech Inc. | 70.05M | 1.22% | 34,451 | - |
| 409 | CSBR | Champions Oncology, Inc. | 69.47M | -1.77% | 7,330 | 59.43M |
| 410 | CRDF | Cardiff Oncology, Inc. | 69.32M | 0.55% | 428,340 | 508.00K |
| 411 | PMVP | PMV Pharmaceuticals, Inc. | 67.73M | 2.42% | 93,047 | - |
| 412 | MNOV | MediciNova, Inc. | 67.68M | 2.61% | 46,975 | 920.48K |
| 413 | RNTX | Rein Therapeutics Inc. | 67.05M | 1.78% | 275,292 | - |
| 414 | HYFT | MindWalk Holdings Corp. | 66.72M | 6.77% | 95,254 | 11.43M |
| 415 | IMA | ImageneBio, Inc. | 65.27M | 1.23% | 465 | 800.00K |
| 416 | OSTX | OS Therapies Incorporated | 64.58M | 0.69% | 207,347 | - |
| 417 | BOLD | Boundless Bio, Inc. | 64.03M | -1.57% | 45,334 | - |
| 418 | INMB | INmune Bio Inc. | 62.45M | 6.64% | 345,041 | 50.00K |
| 419 | XLO | Xilio Therapeutics, Inc. | 61.49M | -1.63% | 4,683 | 64.09M |
| 420 | BSEM | BioStem Technologies, Inc. | 60.78M | 8.10% | 103,394 | 34.59M |
| 421 | HRTX | Heron Therapeutics, Inc. | 59.61M | 4.35% | 2,191,659 | 151.18M |
| 422 | EXOZ | eXoZymes, Inc. | 59.22M | 1.72% | 2,446 | -700.00 |
| 423 | INKT | MiNK Therapeutics, Inc. | 58.94M | -1.42% | 8,157 | - |
| 424 | RNXT | RenovoRx, Inc. | 58.67M | 11.11% | 472,336 | 1.98M |
| 425 | EDSA | Edesa Biotech, Inc. | 55.78M | 1.40% | 18,781 | - |
| 426 | IMMP | Immutep Limited | 55.41M | -1.07% | 48,144 | 5.28M |
| 427 | TCRX | TScan Therapeutics, Inc. | 52.79M | -5.56% | 316,553 | 7.11M |
| 428 | APLM | Apollomics, Inc. | 52.71M | 0.33% | 6,865 | 8.84M |
| 429 | ATYR | aTyr Pharma, Inc. | 51.79M | 4.74% | 387,157 | 190.00K |
| 430 | IBO | Impact BioMedical Inc. | 50.68M | - | 21,928 | 35.00K |
| 431 | TIL | Instil Bio, Inc. | 49.95M | 0.75% | 1,013 | - |
| 432 | MREO | Mereo BioPharma Group plc | 48.69M | -2.59% | 920,857 | 500.00K |
| 433 | FLNA | Filana Therapeutics, Inc. | 46.86M | 11.89% | 323,257 | - |
| 434 | MGX | Metagenomi Therapeutics, Inc. | 46.84M | 2.48% | 226,383 | 13.56M |
| 435 | VRXA | Veraxa Biotech AG | 45.92M | 1.73% | 19,463 | - |
| 436 | GRCE | Grace Therapeutics, Inc. | 45.86M | 2.35% | 69,175 | - |
| 437 | KPTI | Karyopharm Therapeutics Inc. | 45.14M | 3.11% | 619,272 | 146.62M |
| 438 | HYPD | Hyperion DeFi, Inc. | 45.06M | 7.41% | 427,570 | 1.40M |
| 439 | ALPS | Alps Group Inc | 44.93M | -8.66% | 58,327 | 3.74M |
| 440 | MCRB | Seres Therapeutics, Inc. | 44.53M | 3.21% | 40,971 | 1.88M |
| 441 | VERU | Veru Inc. | 44.42M | 0.58% | 83,459 | 16.89M |
| 442 | ALGS | Aligos Therapeutics, Inc. | 43.52M | 3.11% | 53,912 | 31.52M |
| 443 | NTRB | Nutriband Inc. | 43.28M | 3.19% | 6,064 | 1.80M |
| 444 | CNTX | Context Therapeutics Inc. | 42.78M | -6.21% | 1,671,992 | - |
| 445 | CRVO | CervoMed Inc. | 42.03M | 6.51% | 271,624 | 331.30K |
| 446 | RADX | Radiopharm Theranostics Limited | 36.93M | -4.58% | 56,334 | 10.86M |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 35.21M | 3.70% | 101,689 | 35.09M |
| 448 | LITS | Lite Strategy, Inc. | 32.06M | 6.84% | 124,713 | - |
| 449 | ESLA | Estrella Immunopharma, Inc. | 31.89M | 1.20% | 35,404 | - |
| 450 | LTRN | Lantern Pharma Inc. | 31.32M | -2.78% | 66,960 | - |
| 451 | QNCX | Quince Therapeutics, Inc. | 31.29M | -2.77% | 7,166 | - |
| 452 | NXTC | NextCure, Inc. | 31.03M | 1.95% | 142,285 | - |
| 453 | NNVC | NanoViricides, Inc. | 30.98M | 0.74% | 211,761 | - |
| 454 | BYSI | BeyondSpring Inc. | 30.51M | 3.33% | 118,264 | 1.88M |
| 455 | BCTX | BriaCell Therapeutics Corp. | 30.37M | 9.07% | 194,224 | - |
| 456 | GLMD | Galmed Pharmaceuticals Ltd. | 30.09M | 1.75% | 188,249 | - |
| 457 | IGC | IGC Pharma, Inc. | 29.72M | 1.09% | 821,429 | 1.11M |
| 458 | KYNB | Kyntra Bio, Inc. | 28.75M | 1.28% | 11,371 | 4.62M |
| 459 | GNTA | Genenta Science S.p.A. | 28.55M | 3.42% | 12,137 | - |
| 460 | CVM | CEL-SCI Corporation | 28.44M | 2.33% | 163,276 | - |
| 461 | ENLV | Enlivex Ltd. | 27.80M | 4.61% | 130,190 | - |
| 462 | GRDX | GridAI Technologies Corp. | 27.62M | 0.26% | 41,999 | - |
| 463 | DYAI | Dyadic International, Inc. | 27.55M | -1.05% | 49,759 | 3.80M |
| 464 | TVGN | Tevogen Inc. | 27.21M | 2.22% | 7,966 | - |
| 465 | ATOS | Atossa Therapeutics, Inc. | 26.94M | 4.25% | 55,528 | - |
| 466 | LGVN | Longeveron Inc. | 26.08M | 3.90% | 954,504 | 1.19M |
| 467 | ACTU | Actuate Therapeutics, Inc. | 25.24M | 0.48% | 94,105 | - |
| 468 | BRNS | Barinthus Biotherapeutics plc | 25.21M | -0.47% | 3,280 | 14.97M |
| 469 | EVAX | Evaxion A/S | 25.02M | -4.76% | 5,163,303 | 7.53M |
| 470 | JSPR | Jasper Therapeutics, Inc. | 24.56M | -1.37% | 254,184 | - |
| 471 | CELU | Celularity Inc. | 24.43M | 14.56% | 36,859 | 26.55M |
| 472 | ABVC | ABVC BioPharma, Inc. | 23.75M | 8.52% | 90,721 | 797.92K |
| 473 | ALLR | Allarity Therapeutics, Inc. | 23.31M | 8.52% | 97,806 | 345.00K |
| 474 | MRKR | Marker Therapeutics, Inc. | 22.09M | 15.22% | 169,210 | 2.69M |
| 475 | NEUP | Neuphoria Therapeutics Inc. | 21.24M | -1.26% | 16,906 | -13.27K |
| 476 | COCP | Cocrystal Pharma, Inc. | 21.19M | 1.85% | 19,467 | 330.00K |
| 477 | CLRB | Cellectar Biosciences, Inc. | 21.18M | 2.32% | 41,678 | - |
| 478 | CNSY | Cerenome, Inc. | 21.13M | -0.32% | 38,839 | 4.20M |
| 479 | QNTM | Quantum BioPharma Ltd. | 20.73M | 4.19% | 249,476 | - |
| 480 | CALC | CalciMedica, Inc. | 20.64M | -5.26% | 372,282 | - |
| 481 | PLRZ | Polyrizon Ltd. | 20.07M | 3.47% | 51,073 | - |
| 482 | HOWL | Werewolf Therapeutics, Inc. | 20.02M | 0.68% | 71,320 | 21.00M |
| 483 | CYCN | Cyclerion Therapeutics, Inc. | 19.05M | 0.38% | 6,857 | 1.90M |
| 484 | PTN | Palatin Technologies, Inc. | 19.04M | -0.10% | 5,384 | 12.88M |
| 485 | LEXX | Lexaria Bioscience Corp. | 18.82M | -1.13% | 44,282 | 194.00K |
| 486 | PLUR | Pluri Inc. | 18.34M | 4.29% | 15,740 | 1.08M |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 17.98M | 14.53% | 1,950,753 | 7.11M |
| 488 | TVRD | Tvardi Therapeutics, Inc. | 17.92M | 0.53% | 156,814 | - |
| 489 | NCEL | NewcelX Ltd. | 17.44M | -4.42% | 9,106 | - |
| 490 | LPCN | Lipocine Inc. | 17.31M | 2.94% | 19,585 | 1.57M |
| 491 | KALA | KALA BIO, Inc. | 17.11M | 2.39% | 16,232 | - |
| 492 | KTTA | Pasithea Therapeutics Corp. | 16.48M | -0.90% | 28,054 | - |
| 493 | TPST | Tempest Therapeutics, Inc. | 16.46M | -3.74% | 92,666 | - |
| 494 | HIND | Vyome Holdings, Inc. | 16.42M | 3.09% | 19,451 | 129.73K |
| 495 | PBM | Psyence Biomedical Ltd. | 16.25M | -4.70% | 151,723 | - |
| 496 | AKTX | Akari Therapeutics, Plc | 15.41M | 0.20% | 13,957 | - |
| 497 | PASG | Passage Bio, Inc. | 14.98M | 2.99% | 29,239 | - |
| 498 | ICU | SeaStar Medical Holding Corporation | 14.72M | - | 50,284 | 1.71M |
| 499 | SNTI | Senti Biosciences Holdings, Inc. | 14.49M | 8.18% | 187,217 | 55.00K |
| 500 | OSRH | OSR Health, Inc. | 14.39M | -4.65% | 18,915,224 | 1.81M |